Gary Disbrow

Dr. Gary Disbrow is the Director of the Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services. BARDA invests in the innovation, advanced R&D, acquisition, and manufacturing of medical countermeasures – vaccines, therapeutics, and diagnostic tools needed to combat health security threats. BARDA has established hundreds of public-private sector partnerships. As of February 2024, BARDA has a portfolio of 87 products that have earned FDA regulatory approval, licensure, or clearance. Dr. Disbrow joined BARDA in January of 2007 and has held a variety of positions related to medical countermeasures against an array of threats to national security and public health.